Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction
Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure
Mechanical circulatory support devices in advanced heart failure: 2020 and beyond
Dilated cardiomyopathy: so many cardiomyopathies!
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions
Angiotensin–neprilysin inhibition versus enalapril in heart failure
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.